Cargando…
Antibody interference and response kinetics of isatuximab plus pomalidomide and dexamethasone in multiple myeloma
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528829/ https://www.ncbi.nlm.nih.gov/pubmed/34671024 http://dx.doi.org/10.1038/s41408-021-00562-9 |
| _version_ | 1784586333777297408 |
|---|---|
| author | Hulin, Cyrille Beksac, Meral Goodman, Hugh J. Spicka, Ivan Alegre, Adrian Prince, Miles Campana, Frank Finn, Greg Le-Guennec, Solenn Macé, Sandrine Muccio, Stéphane Tavernier, Alexandra Rouchon, Marie-Claude Richardson, Paul G. |
| author_facet | Hulin, Cyrille Beksac, Meral Goodman, Hugh J. Spicka, Ivan Alegre, Adrian Prince, Miles Campana, Frank Finn, Greg Le-Guennec, Solenn Macé, Sandrine Muccio, Stéphane Tavernier, Alexandra Rouchon, Marie-Claude Richardson, Paul G. |
| author_sort | Hulin, Cyrille |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8528829 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85288292021-10-22 Antibody interference and response kinetics of isatuximab plus pomalidomide and dexamethasone in multiple myeloma Hulin, Cyrille Beksac, Meral Goodman, Hugh J. Spicka, Ivan Alegre, Adrian Prince, Miles Campana, Frank Finn, Greg Le-Guennec, Solenn Macé, Sandrine Muccio, Stéphane Tavernier, Alexandra Rouchon, Marie-Claude Richardson, Paul G. Blood Cancer J Correspondence Nature Publishing Group UK 2021-10-20 /pmc/articles/PMC8528829/ /pubmed/34671024 http://dx.doi.org/10.1038/s41408-021-00562-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Hulin, Cyrille Beksac, Meral Goodman, Hugh J. Spicka, Ivan Alegre, Adrian Prince, Miles Campana, Frank Finn, Greg Le-Guennec, Solenn Macé, Sandrine Muccio, Stéphane Tavernier, Alexandra Rouchon, Marie-Claude Richardson, Paul G. Antibody interference and response kinetics of isatuximab plus pomalidomide and dexamethasone in multiple myeloma |
| title | Antibody interference and response kinetics of isatuximab plus pomalidomide and dexamethasone in multiple myeloma |
| title_full | Antibody interference and response kinetics of isatuximab plus pomalidomide and dexamethasone in multiple myeloma |
| title_fullStr | Antibody interference and response kinetics of isatuximab plus pomalidomide and dexamethasone in multiple myeloma |
| title_full_unstemmed | Antibody interference and response kinetics of isatuximab plus pomalidomide and dexamethasone in multiple myeloma |
| title_short | Antibody interference and response kinetics of isatuximab plus pomalidomide and dexamethasone in multiple myeloma |
| title_sort | antibody interference and response kinetics of isatuximab plus pomalidomide and dexamethasone in multiple myeloma |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528829/ https://www.ncbi.nlm.nih.gov/pubmed/34671024 http://dx.doi.org/10.1038/s41408-021-00562-9 |
| work_keys_str_mv | AT hulincyrille antibodyinterferenceandresponsekineticsofisatuximabpluspomalidomideanddexamethasoneinmultiplemyeloma AT beksacmeral antibodyinterferenceandresponsekineticsofisatuximabpluspomalidomideanddexamethasoneinmultiplemyeloma AT goodmanhughj antibodyinterferenceandresponsekineticsofisatuximabpluspomalidomideanddexamethasoneinmultiplemyeloma AT spickaivan antibodyinterferenceandresponsekineticsofisatuximabpluspomalidomideanddexamethasoneinmultiplemyeloma AT alegreadrian antibodyinterferenceandresponsekineticsofisatuximabpluspomalidomideanddexamethasoneinmultiplemyeloma AT princemiles antibodyinterferenceandresponsekineticsofisatuximabpluspomalidomideanddexamethasoneinmultiplemyeloma AT campanafrank antibodyinterferenceandresponsekineticsofisatuximabpluspomalidomideanddexamethasoneinmultiplemyeloma AT finngreg antibodyinterferenceandresponsekineticsofisatuximabpluspomalidomideanddexamethasoneinmultiplemyeloma AT leguennecsolenn antibodyinterferenceandresponsekineticsofisatuximabpluspomalidomideanddexamethasoneinmultiplemyeloma AT macesandrine antibodyinterferenceandresponsekineticsofisatuximabpluspomalidomideanddexamethasoneinmultiplemyeloma AT mucciostephane antibodyinterferenceandresponsekineticsofisatuximabpluspomalidomideanddexamethasoneinmultiplemyeloma AT tavernieralexandra antibodyinterferenceandresponsekineticsofisatuximabpluspomalidomideanddexamethasoneinmultiplemyeloma AT rouchonmarieclaude antibodyinterferenceandresponsekineticsofisatuximabpluspomalidomideanddexamethasoneinmultiplemyeloma AT richardsonpaulg antibodyinterferenceandresponsekineticsofisatuximabpluspomalidomideanddexamethasoneinmultiplemyeloma |